Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page
- Check2 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.4%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference0.6%
- Check56 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check63 days agoChange DetectedThe page has undergone significant content removal regarding the details of a clinical study on ligelizumab for chronic spontaneous urticaria, including its purpose, methodology, and key inclusion/exclusion criteria. Additionally, there are updates to the revision number and masking description.SummaryDifference14%
- Check78 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check85 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.